Growth Metrics

Iridex (IRIX) Accumulated Expenses (2011 - 2026)

Iridex's quarterly Accumulated Expenses came in at $692000.0 in Q2 2026, down 28.59% year-on-year from $969000.0 in Q2 2025, and down 70.43% quarter-over-quarter from $2.3 million in Q1 2026.

Iridex has reported Accumulated Expenses for 16 years, with the latest figure at $692000.0 in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses fell 28.59% year-over-year to $692000.0; the trailing twelve-month figure through Apr 2026 stood at $692000.0 (down 28.59% YoY), and the FY2026 full-year result was $2.3 million, up 368.0% from the prior year.
  • Accumulated Expenses for Q2 2026 stood at $692000.0, down from $2.3 million in the prior quarter.
  • The five-year high for Accumulated Expenses was $3.2 million in Q1 2022, with the low at $117000.0 in Q2 2022.
  • Average Accumulated Expenses over 5 years is $1.5 million, with a median of $1.8 million recorded in 2022.
  • Peak annual rise in Accumulated Expenses reached 2226.26% in 2022, while the deepest fall reached 94.74% in 2022.
  • Tracing IRIX's Accumulated Expenses over 5 years: stood at $168000.0 in 2022, then jumped by 863.69% to $1.6 million in 2023, then sank by 69.12% to $500000.0 in 2024, then surged by 286.4% to $1.9 million in 2025, then tumbled by 64.18% to $692000.0 in 2026.
  • The last three Accumulated Expenses figures came in at $692000.0 (Q2 2026), $2.3 million (Q1 2026), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Iridex 18.87 Mn 14.27 Mn 4.74 Mn

Historic Data

Download Data 🔒
DateValue
Apr 4, 2026 692,000.00
Jan 3, 2026 2.34 Mn
Sep 27, 2025 1.93 Mn
Jun 28, 2025 584,000.00
Mar 29, 2025 969,000.00
Dec 28, 2024 57,000.00
Sep 28, 2024 1.84 Mn
Jun 29, 2024 868,000.00
Mar 30, 2024 1.11 Mn
Dec 30, 2023 308,000.00
Sep 30, 2023 2.20 Mn
Jul 1, 2023 2.16 Mn
Apr 1, 2023 2.81 Mn
Dec 31, 2022 168,000.00
Oct 1, 2022 1.71 Mn
Jul 2, 2022 131,000.00
Apr 2, 2022 1.65 Mn
Jan 1, 2022 100,000.00
Oct 2, 2021 99,000.00
Jul 3, 2021 99,000.00
Apr 3, 2021 1.45 Mn
Jan 2, 2021 990,000.00
Sep 26, 2020 1.68 Mn
Mar 28, 2020 259,000.00
Dec 28, 2019 2.40 Mn
Sep 28, 2019 376,000.00
Jun 29, 2019 490,000.00
Mar 30, 2019 2.09 Mn
Dec 29, 2018 2.96 Mn
Sep 29, 2018 2.64 Mn
Jun 30, 2018 2.39 Mn
Mar 31, 2018 1.74 Mn
Dec 30, 2017 293,000.00
Sep 30, 2017 1.68 Mn
Jul 1, 2017 666,000.00
Apr 1, 2017 649,000.00
Dec 31, 2016 66,000.00
Oct 1, 2016 570,000.00
Jul 2, 2016 610,000.00
Apr 2, 2016 610,000.00
Jan 2, 2016 603,000.00
Oct 3, 2015 528,000.00
Jul 4, 2015 520,000.00
Apr 4, 2015 511,000.00
Jan 3, 2015 469,000.00
Sep 27, 2014 538,000.00
Jun 28, 2014 506,000.00
Mar 29, 2014 484,000.00
Dec 28, 2013 468,000.00
Sep 28, 2013 472,000.00
Jun 29, 2013 457,000.00
Mar 30, 2013 446,000.00
Dec 29, 2012 453,000.00
Sep 29, 2012 528,000.00
Jun 30, 2012 525,000.00
Mar 31, 2012 539,000.00
Dec 31, 2011 556,000.00
Oct 1, 2011 632,000.00
Jul 2, 2011 628,000.00
Jan 1, 2011 607,000.00